Skip to content

Treatment / Procedure

Melasma with IPL / BBL: When, in Whom, with Which Risks?

A guide on patient selection, risk of PIH and rebound pigmentation, combination treatments, and why it is not the first choice in every case of melasma in melasma treatment with IPL/BBL.

Preliminary evidence

Short answerIPL/BBL can reduce pigment in certain selected patients with melasma; however, melasma is a chronic condition prone to recurrence and influenced by inflammation, UV/visible light, and hormonal factors. Especially in darker phototypes or with an active tan, it is not the first-line option for every patient due to the risk of postinflammatory hyperpigmentation and rebound darkening.

In which melasma can it be considered?

It can be considered as part of a combined plan in selected cases where a more superficial/epidermal pigment component is predominant, the skin type is suitable, and sun protection as well as medical pigment control are well established.

Why might light therapy alone not be sufficient?

Melasma is not merely melanin accumulation. It can have vascular, inflammatory, hormonal, and skin barrier components. Therefore, it is addressed together with sun and visible light protection, topical treatments, and, when necessary, other energy/peeling options.

Risks

Aggressive energy, recent sun exposure, dark skin, and a tendency toward active melasma can lead to a temporary or permanent increase in pigment. For this reason, a test spot, low-step parameters, and strict photoprotection are important.

Our approach at our Bodrum clinic

We do not automatically recommend IPL/BBL as a first choice in melasma. We first evaluate the pigment type, phototype, summer-winter sun exposure, and previous treatment response; we use it only in appropriate patients as a component of a combined approach.

References

  1. Wat H, et al. Application of intense pulsed light in dermatologic disease: systematic review. PMID: 24495252.
  2. Intense pulsed light in melasma: clinical literature summarized in systematic reviews and comparative studies.

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.